Intranasal administration of interferon beta bypasses the blood–brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis
- 1 June 2004
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 151 (1-2) , 66-77
- https://doi.org/10.1016/j.jneuroim.2004.02.011
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosisMultiple Sclerosis Journal, 2002
- Sniffing neuropeptides: a transnasal approach to the human brainNature Neuroscience, 2002
- Interferon-?? Therapy in Multiple SclerosisDrugs, 2001
- Delivery of Neurotrophic Factors to the Central Nervous SystemClinical Pharmacokinetics, 2001
- Signaling pathways activated by interferonsExperimental Hematology, 1999
- Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b.Journal of Clinical Investigation, 1997
- Isolation and Expression of Rat Interferon β Gene and Growth-Inhibitory Effect of Its Expression on Rat Glioma CellsBiochemical and Biophysical Research Communications, 1997
- Delivery of125I-NGF to the Brain via the Olfactory RouteDrug Delivery, 1997
- Interferon β decreases T cell activation and interferon γ production in multiple sclerosisJournal of Neuroimmunology, 1993
- Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and miceArchiv für die gesamte Virusforschung, 1981